An international team of scientists has made a breakthrough which could help halt the growth of diabetes. A set of genes that appear to raise the risk of adult-onset diabetes has been identified, promising a test that can predict who is likely to develop the disease.

A new study says that acute exercise – as little as 15 minutes a day – can have a profound influence on preventing and fighting the disease.

At least 6 million Americans expected to buy Alli at a cost of 2 dollars a day, beginning this summer. For those that don’t reduce their fat intake while taking Alli, will be in for a surprise.

Self-treatment with a biofeedback device that guides breathing can significantly lower blood pressure among patients with type 2 diabetes.

An analysis of data from four clinical trials suggests that statin therapy is associated with regression of coronary atherosclerosis.

A new Joslin Diabetes Center-led study has shown conclusively that a neuropeptide, melanin concentrating hormone (MCH), found in the brain and known for its role in increasing appetite in people, plays a role in the growth of insulin-producing beta cells and the secretion of insulin.

Over-65s who drink four or more caffeinated beverages every day may reduce their risk of heart disease by a whopping 53 per cent, suggests research from the US.

Patients taking the diabetes drug Avandia may have a higher risk of hip and other fractures because the medicine decreases bone formation, according to new research by doctors in New Zealand.

Patients with diabetes undergoing coronary stent implantation for symptomatic acute coronary syndrome have a lower response to a 600-mg dose of clopidogrel, which was linked with a decrease in platelet response.

A new test, called the BIGTT test, simultaneously measures pancreatic beta-cell function, insulin sensitivity, and glucose tolerance.